Finerenone in Black Patients With Type 2 Diabetes and CKD: A Post hoc Analysis of the Pooled FIDELIO-DKD and FIGARO-DKD Trials

By sjmartinez • December 4, 2023

Flack JM, Agarwal R, Anker SD, Pitt B, Ruilope LM, Rossing P, Adler SG, Fried L, Jamerson K, Toto R, Brinker M, Farjat AE, Kolkhof P, Lawatscheck R, Joseph A, Bakris GL; FIDELIO-DKD and FIGARO-DKD Investigators. Finerenone in Black Patients With Type 2 Diabetes and CKD: A Post hoc Analysis of the Pooled FIDELIO-DKD and FIGARO-DKD Trials. Kidney Med. 2023 Sep 28;5(12):100730. doi: 10.1016/j.xkme.2023.100730. PMID: 38046911; PMCID: PMC10692708.

Tags: Cardiorenal, Chronic kidney disease, Clinical Trial, Finerenone, Harbor UCLA, Nephrology, Publications, Race, Type 2 diabetes

Correlation analysis of hematocrit level and coronary heart disease in patients with chest pain: a case-control study

Xie J, Cao H, Jin D, Wang Y, Li X, Budoff M, Jiang H, Ren J. Correlation analysis of hematocrit level and coronary heart disease[...]

Dextroposition of the Heart From Tension Hydrothorax in a Patient With Malignant Pleural Effusion

Lu JY, Fritzmann E, Hsia DW, Lanks C. Dextroposition of the Heart From Tension Hydrothorax in a Patient With Malignant Pleural Effusion. Cureus. 2025 Apr[...]

A Multidimensional Diagnostic Approach for Chronic Obstructive Pulmonary Disease

COPDGene 2025 Diagnosis Working Group and CanCOLD Investigators; Bhatt SP, Abadi E, Anzueto A, Bodduluri S, Casaburi R, Castaldi PJ, Cho MH, Comellas AP, Conrad[...]